Insider · CIK 0001817199
Christine Ring
officer
Files at NRIX (Nurix Therapeutics, Inc.). First filing Oct 15, 2024, latest Oct 2, 2026.
In brief
Christine Ring files SEC Form 4 as officer at NRIX (Nurix Therapeutics, Inc.). Since Oct 15, 2024, Christine Ring has reported 0 open-market buys worth $0 and 25 open-market sells worth $4.0M, the latest filed on Oct 2, 2026.
A track record needs three past buys with six months of prices behind them; Christine Ring has 0, so none is measured yet.
The newest scored trade: sold $134k of NRIX on Oct 2, 2026, filed Oct 2, 2026, scored 1 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 18 sells worth $3.4M.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 25
$0 bought, $4.0M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NRIX: Nurix Therapeutics, Inc.
NRIXOct 9, 2026 · close 22.35
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 1Weak | Nurix Therapeutics, Inc. | $134k 5,786 shares | -39% | +153% from low-17% from high | |
| 9Weak | Nurix Therapeutics, Inc. | $149k 5,787 shares | -39% | - | |
| 31Weak | Nurix Therapeutics, Inc. | $382k 16,589 shares | -65% | +182% from low-6% from high | |
| 29Weak | Nurix Therapeutics, Inc. | $90k 3,847 shares | -16% | +186% from low-5% from high | |
| 11Weak | Nurix Therapeutics, Inc. | $259k 11,008 shares | -45% | +191% from low-1% from high | |
| 27Weak | Nurix Therapeutics, Inc. | $581k 28,935 shares | -68% | +173% from low0% from high | |
| 1Weak | Nurix Therapeutics, Inc. | $135k 8,148 shares | -38% | +99% from low-24% from high | |
| 31Weak | Nurix Therapeutics, Inc. | $138k 8,148 shares | -31% | +105% from low-21% from high | |
| 24Weak | Nurix Therapeutics, Inc. | $90k 5,394 shares | -17% | +104% from low-22% from high | |
| 22Weak | Nurix Therapeutics, Inc. | $53k 3,214 shares | -9% | +103% from low-22% from high | |
| 10Weak | Nurix Therapeutics, Inc. | $124k 8,148 shares | -24% | +88% from low-28% from high | |
| 11Weak | Nurix Therapeutics, Inc. | $126k 8,148 shares | -19% | +92% from low-26% from high | |
| 33Weak | Nurix Therapeutics, Inc. | $238k 14,261 shares | -25% | +103% from low-22% from high | |
| 23Weak | Nurix Therapeutics, Inc. | $73k 4,421 shares | -7% | +100% from low-23% from high | |
| 3Weak | Nurix Therapeutics, Inc. | $69k 3,760 shares | -7% | +121% from low-15% from high | |
| 0Weak | Nurix Therapeutics, Inc. | $67k 3,760 shares | -7% | +119% from low-16% from high | |
| 10Weak | Nurix Therapeutics, Inc. | $642k 37,600 shares | -42% | +108% from low-22% from high | |
| 21Weak | Nurix Therapeutics, Inc. | $47k 3,644 shares | -7% | +55% from low-55% from high | |
| 21Weak | Nurix Therapeutics, Inc. | $46k 3,841 shares | -8% | +35% from low-58% from high | |
| 21Weak | Nurix Therapeutics, Inc. | $33k 2,894 shares | -7% | +31% from low-59% from high | |
| 0Weak | Nurix Therapeutics, Inc. | $125k 5,760 shares | -17% | - | |
| 9Weak | Nurix Therapeutics, Inc. | $82k 3,290 shares | -10% | - | |
| 11Weak | Nurix Therapeutics, Inc. | $140k 5,760 shares | -17% | - | |
| 30Weak | Nurix Therapeutics, Inc. | $102k 4,182 shares | -13% | - | |
| 0Weak | Nurix Therapeutics, Inc. | $82k 3,290 shares | -12% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 2, 2026 | NRIX NURIX THERAPEUTICS INC | 5,786 0.01% of outstanding | $135k | Oct 2, 2026 | $621k |
| Sep 2, 2026 | NRIX NURIX THERAPEUTICS, INC. | 5,787 0.01% of outstanding | $151k | Sep 2, 2026 | $1.3M |
| Aug 3, 2026 | NRIX NURIX THERAPEUTICS INC | 16,589 0.02% of outstanding | $385k | Aug 3, 2026 | $1.1M |
| Jul 2, 2026 | NRIX NURIX THERAPEUTICS, INC. | 11,008 0.01% of outstanding | $263k | Jul 2, 2026 | $998k |
| Jun 25, 2026 | NRIX NURIX THERAPEUTICS INC | 28,935 0.03% of outstanding | $558k | Jun 25, 2026 | $542k |
| Jun 2, 2026 | NRIX NURIX THERAPEUTICS INC | 8,148 0.01% of outstanding | $142k | Jun 2, 2026 | $406k |
| May 4, 2026 | NRIX NURIX THERAPEUTICS INC | 8,148 0.01% of outstanding | $137k | May 4, 2026 | $631k |
| May 1, 2026 | NRIX NURIX THERAPEUTICS INC | 5,394 0.01% of outstanding | $90k | May 1, 2026 | $541k |
| Apr 2, 2026 | NRIX NURIX THERAPEUTICS INC | 8,148 0.01% of outstanding | $126k | Apr 2, 2026 | $433k |
| Mar 2, 2026 | NRIX NURIX THERAPEUTICS INC | 8,148 0.01% of outstanding | $130k | Mar 2, 2026 | $374k |
| Feb 9, 2026 | NRIX NURIX THERAPEUTICS, INC. | 14,261 0.01% of outstanding | $240k | Feb 9, 2026 | $778k |
| Dec 18, 2025 | NRIX NURIX THERAPEUTICS, INC. | 7,520 0.01% of outstanding | $137k | Dec 18, 2025 | $642k |
| Nov 24, 2025 | NRIX NURIX THERAPEUTICS INC | 37,600 0.05% of outstanding | $630k | Nov 24, 2025 | none |
| Jan 31, 2025 | NRIX NURIX THERAPEUTICS, INC. | 5,760 0.01% of outstanding | $115k | Jan 31, 2025 | $460k |
| Jan 2, 2025 | NRIX NURIX THERAPEUTICS, INC. | 5,760 0.01% of outstanding | $109k | Jan 2, 2025 | $430k |
| Dec 2, 2024 | NRIX NURIX THERAPEUTICS INC | 5,760 0.01% of outstanding | $127k | Dec 2, 2024 | $658k |
| Nov 4, 2024 | NRIX NURIX THERAPEUTICS INC | 3,290 0.00% of outstanding | $81k | Nov 4, 2024 | $823k |
| Nov 1, 2024 | NRIX NURIX THERAPEUTICS INC | 5,760 0.01% of outstanding | $142k | Nov 1, 2024 | $683k |
Transactions
The newest 50 of 108 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,786 | $8.72 | $50k | 14,896 | 11 d ago |
| Oct 2, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,786 | $23.19 | $134k | 9,110 | 11 d ago |
| Oct 2, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -5,786 | $0.00 | $0 | 111,251 | 11 d ago |
| Sep 2, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,787 | $8.72 | $50k | 14,897 | 41 d ago |
| Sep 2, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,387 | $25.69 | $138k | 9,510 | 41 d ago |
| Sep 2, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -400 | $26.64 | $11k | 9,110 | 41 d ago |
| Sep 2, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -5,787 | $0.00 | $0 | 117,037 | 41 d ago |
| Aug 3, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,787 | $8.72 | $50k | 25,699 | Aug 3, 2026 |
| Aug 3, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -16,589 | $23.05 | $382k | 9,110 | Aug 3, 2026 |
| Aug 3, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -5,787 | $0.00 | $0 | 122,824 | Aug 3, 2026 |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +3,750 | $0.00 | $0 | 17,329 | Jul 30, 2026 |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +2,858 | $0.00 | $0 | 20,187 | Jul 30, 2026 |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +3,572 | $0.00 | $0 | 23,759 | Jul 30, 2026 |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock | -3,847 | $23.38 | $90k | 19,912 | Jul 30, 2026 |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,750 | $0.00 | $0 | 11,250 | Jul 30, 2026 |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,858 | $0.00 | $0 | 20,009 | Jul 30, 2026 |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,572 | $0.00 | $0 | 39,303 | Jul 30, 2026 |
| Jul 2, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,221 | $1.86 | $9,711 | 18,800 | Jul 2, 2026 |
| Jul 2, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,787 | $8.72 | $50k | 24,587 | Jul 2, 2026 |
| Jul 2, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -11,008 | $23.56 | $259k | 13,579 | Jul 2, 2026 |
| Jul 2, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -5,221 | $0.00 | $0 | 0 | Jul 2, 2026 |
| Jul 2, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -5,787 | $0.00 | $0 | 128,611 | Jul 2, 2026 |
| Jun 25, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +13,333 | $7.26 | $97k | 26,912 | Jun 25, 2026 |
| Jun 25, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +15,602 | $8.72 | $136k | 42,514 | Jun 25, 2026 |
| Jun 25, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -28,935 | $20.06 | $581k | 13,579 | Jun 25, 2026 |
| Jun 25, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -13,333 | $0.00 | $0 | 0 | Jun 25, 2026 |
| Jun 25, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -15,602 | $0.00 | $0 | 134,398 | Jun 25, 2026 |
| Jun 2, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +3,422 | $1.86 | $6,365 | 21,727 | Jun 2, 2026 |
| Jun 2, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,148 | $16.60 | $135k | 13,579 | Jun 2, 2026 |
| Jun 2, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -3,422 | $0.00 | $0 | 5,221 | Jun 2, 2026 |
| May 4, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,148 | $16.96 | $138k | 18,305 | May 4, 2026 |
| May 1, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,394 | $16.76 | $90k | 26,453 | May 1, 2026 |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +2,000 | $0.00 | $0 | 28,453 | Apr 30, 2026 |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +3,750 | $0.00 | $0 | 32,203 | Apr 30, 2026 |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +2,858 | $0.00 | $0 | 35,061 | Apr 30, 2026 |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock | -3,214 | $16.65 | $53k | 31,847 | Apr 30, 2026 |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,000 | $0.00 | $0 | 0 | Apr 30, 2026 |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,750 | $0.00 | $0 | 15,000 | Apr 30, 2026 |
| Apr 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,858 | $0.00 | $0 | 22,867 | Apr 30, 2026 |
| Apr 2, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,148 | $15.24 | $124k | 26,453 | Apr 2, 2026 |
| Mar 2, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,148 | $15.44 | $126k | 34,601 | Mar 2, 2026 |
| Feb 10, 2026 | NRIX Nurix Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +93,750 | $0.00 | $0 | 93,750 | Feb 10, 2026 |
| Feb 10, 2026 | NRIX Nurix Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +42,875 | $0.00 | $0 | 42,875 | Feb 10, 2026 |
| Feb 9, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -14,261 | $16.66 | $238k | 42,749 | Feb 9, 2026 |
| Jan 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +1,925 | $0.00 | $0 | 52,822 | Jan 30, 2026 |
| Jan 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +2,000 | $0.00 | $0 | 54,822 | Jan 30, 2026 |
| Jan 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +3,750 | $0.00 | $0 | 58,572 | Jan 30, 2026 |
| Jan 30, 2026 | NRIX Nurix Therapeutics, Inc. | MOption exercise Common Stock | +2,859 | $0.00 | $0 | 61,431 | Jan 30, 2026 |
| Jan 30, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock | -4,333 | $16.58 | $72k | 57,098 | Jan 30, 2026 |
| Jan 30, 2026 | NRIX Nurix Therapeutics, Inc. | SOpen-market sale Common Stock | -88 | $17.37 | $1,529 | 57,010 | Jan 30, 2026 |
50 of 108 rows shown.
Questions about Christine Ring
Answered from the filings on this page, as of the latest one.
Is Christine Ring buying or selling?
In the last 12 months Christine Ring reported 0 open-market buys worth $0 and 18 open-market sells worth $3.4M on SEC Form 4; the latest was sold $134k of NRIX on Oct 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Christine Ring's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christine Ring has 0.
Where does Christine Ring file Form 4?
Christine Ring has filed Form 4 at NRIX (Nurix Therapeutics, Inc.) as Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.